Skip to content
Open in App
Neurocrine logo

Neurocrine

web2

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurolo...

Symbol · 1NBIX
Company profile

About

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associated with Huntington’s disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer’s disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Explore by sector

Explore this sector

Market identity

Exchange listings

Listing identities only. Orbitrum does not publish live prices or market performance on this public profile.

People

Company team

LV

Leslie V. Norwalk

Independent Director

Company leadership profile.

CA

Christine Ann Poon

Independent Director

Company leadership profile.

SS

Shalini Sharp

Independent Director

Company leadership profile.

SA

Stephen A. Sherwin

Independent Director

Company leadership profile.

WH

William H. Rastetter

Independent Chairman of the Board

Company leadership profile.

KW

Kyle W. Gano

President, CEO & Director

Company leadership profile.

RF

Richard F. Pops

Independent Director

Company leadership profile.

GA

Gary A. Lyons

Independent Director

Company leadership profile.

KC

Kevin C. Gorman

Director

Company leadership profile.

GJ

George J. Morrow

Independent Director

Company leadership profile.

JM

Johanna Mercier

Independent Director

Company leadership profile.

Expert coverage

1 expert evaluated Neurocrine.

Orbitrum research

Experts evaluating Neurocrine

Explore the public profiles of experts who have evaluated this project.

Orbitrum Academy

Learn how to read a project assessment